| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.008 | 1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.006 | 1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.0072 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |